ZBIO

31.33

0.26% 0.08

Vorhandelsmarkt: 29.40 -1.93 -6.16%

Zenas Biopharma Inc (ZBIO)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

$31.25

Offen:

$31.17

24-Stunden-Volumen:

425.16K

Relative Volume:

1.20

Marktkapitalisierung:

$1.32B

Einnahmen:

Nettoeinkommen (Verlust:

KGV:

EPS:

Netto-Cashflow:

1W Leistung:

-1.48%

1M Leistung:

+43.98%

6M Leistung:

+162.84%

1J Leistung:

+53.05%

1-Tages-Spanne:

$30.30

$31.56

1-Wochen-Bereich:

$26.88

$32.00

52-Wochen-Spanne:

$5.83

$34.33

Zenas Biopharma Inc Stock (ZBIO) Company Profile

Firmenname

Zenas Biopharma Inc

Sektor

Healthcare (1136)

Branche

Biotechnology (633)

Telefon

857-271-2954

Adresse

852 WINTER STREET, SUITE 250, WALTHAM

Mitarbeiter

130

Twitter

Nächster Verdiensttermin

Neueste SEC-Einreichungen

ZBIO's Discussions on Twitter

Vergleichen Sie ZBIO mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ZBIO Zenas Biopharma Inc	31.33	1.47B	0	0	0	0.00
VRTX Vertex Pharmaceuticals Inc	426.00	109.11B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	642.25	68.50B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	434.07	60.25B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	826.28	50.39B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	186.23	40.44B	447.02M	-1.18B	-868.57M	-6.1812

Zenas Biopharma Inc Stock (ZBIO) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-03-20	Eingeleitet	Wedbush	Outperform
2025-02-04	Eingeleitet	Wolfe Research	Outperform
2024-12-16	Eingeleitet	H.C. Wainwright	Buy
2024-11-05	Eingeleitet	Rodman & Renshaw	Buy
2024-10-08	Eingeleitet	Citigroup	Buy
2024-10-08	Eingeleitet	Guggenheim	Buy
2024-10-08	Eingeleitet	Jefferies	Buy
2024-10-08	Eingeleitet	Morgan Stanley	Overweight

Alle ansehen

Zenas Biopharma Inc Aktie (ZBIO) Neueste Nachrichten

02:45 AM

Will Zenas BioPharma Inc. stock sustain high P E ratiosJuly 2025 PreEarnings & Reliable Breakout Stock Forecasts - newser.com

02:45 AM

Nov 03, 2025

Will Zenas BioPharma Inc. benefit from macro trendsMarket Rally & Long-Term Safe Investment Ideas - newser.com

Nov 03, 2025

Is Zenas BioPharma Inc. stock a dividend growth opportunityPortfolio Return Report & Real-Time Stock Movement Alerts - newser.com

Nov 03, 2025

How risky is Zenas BioPharma Inc. stock nowEarnings Risk Report & Real-Time Volume Spike Alerts - newser.com

Nov 03, 2025

What dividend safety score for Zenas BioPharma Inc. stockJuly 2025 Summary & Stock Timing and Entry Methods - newser.com

Nov 03, 2025

Price momentum metrics for Zenas BioPharma Inc. explainedWeekly Market Report & Reliable Price Breakout Signals - newser.com

Nov 03, 2025

How to track smart money flows in Zenas BioPharma Inc.Dollar Strength & Fast Entry High Yield Stock Tips - newser.com

Nov 03, 2025

Multi asset correlation models including Zenas BioPharma Inc.2025 Price Momentum & Weekly Hot Stock Watchlists - newser.com

Nov 03, 2025

Nov 02, 2025

How to build a dashboard for Zenas BioPharma Inc. stockJuly 2025 Volume & Real-Time Stock Price Movement Reports - newser.com

Nov 02, 2025

Applying chart zones and confluence areas to Zenas BioPharma Inc.July 2025 Closing Moves & Reliable Volume Spike Trade Alerts - newser.com

Nov 02, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Zenas BioPharma, Inc. (ZBIO) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire

Nov 02, 2025

How Zenas BioPharma Inc. stock reacts to inflationary pressuresMarket Growth Review & Low Risk Entry Point Tips - newser.com

Nov 02, 2025

Has Zenas BioPharma Inc. formed a bullish divergenceTrade Analysis Report & Weekly Momentum Picks - newser.com

Nov 02, 2025

Nov 01, 2025

Is Zenas BioPharma Inc. stock ready for breakoutQuarterly Portfolio Review & High Conviction Trade Alerts - newser.com

Nov 01, 2025

Leading vs lagging indicators on Zenas BioPharma Inc. performanceJuly 2025 Outlook & Daily Growth Stock Investment Tips - newser.com

Nov 01, 2025

Oct 31, 2025

Citigroup Raises Zenas BioPharma (NASDAQ:ZBIO) Price Target to $46.00 - MarketBeat

Oct 31, 2025

Zenas BioPharma, Inc.Common Stock (Nasdaq:ZBIO) Stock Quote - FinancialContent

Oct 31, 2025

Weiss Ratings Reiterates Sell (E+) Rating for Zenas BioPharma (NASDAQ:ZBIO) - MarketBeat

Oct 31, 2025

HC Wainwright Reduces Earnings Estimates for Zenas BioPharma - MarketBeat

Oct 31, 2025

Strategies to average down on Zenas BioPharma Inc.Insider Selling & Technical Entry and Exit Tips - newser.com

Oct 31, 2025

Published on: 2025-10-31 01:53:58 - newser.com

Oct 31, 2025

Oct 30, 2025

Zenas BioPharma (NASDAQ:ZBIO) Shares Down 7.3%Here's What Happened - MarketBeat

Oct 30, 2025

Is Zenas BioPharma Inc a good long term investmentPortfolio Allocation Tips & Free Phenomenal Trading Returns - earlytimes.in

Oct 30, 2025

Zenas BioPharma (ZBIO) Price Target Increased by 21.59% to 40.22 - MSN

Oct 30, 2025

Promising Phase 2 Results and Strategic Licensing Drive Buy Rating for Zenas BioPharma - TipRanks

Oct 30, 2025

Oct 29, 2025

Zenas BioPharma (NASDAQ:ZBIO) Stock Price Expected to Rise, HC Wainwright Analyst Says - MarketBeat

Oct 29, 2025

Oct 28, 2025

Zenas BioPharma (NASDAQ:ZBIO) Given Outperform Rating at Wedbush - MarketBeat

Oct 28, 2025

Zenas BioPharma, Inc. (NASDAQ:ZBIO) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Oct 28, 2025

ZBIO: Citigroup Raises Price Target, Maintains Buy Rating | ZBIO Stock News - GuruFocus

Oct 28, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Zenas BioPharma, Inc. (ZBIO) And Encourages Stockholders to Reach Out - ACCESS Newswire

Oct 28, 2025

ZBIO: Morgan Stanley Raises Price Target, Maintains Overweight R - GuruFocus

Oct 28, 2025